Biotech investor diligence

Sourced, claim-verified diligence on any drug, target, or indication.

Ask a diligence question and DAVAI Trace assembles a fully sourced report — every claim traceable to its source, graded for evidence strength. It never issues price targets or buy/sell calls.

No credit card requiredUnlimited grounded chatFull provenance
Diligence report · Olaparib
Target · Indication
PARP inhibition in BRCA-mutant ovarian cancer
Evidence
Strong
14 sources

Significant PFS benefit vs. placebo as maintenance therapy (HR 0.30).

ClinicalTrials.govStrong

Overall-survival benefit sustained at the long-term follow-up analysis.

PubMedModerate

Evidence resolves to sources you can open

PubMedClinicalTrials.govChEMBLOpen TargetsDailyMedDrugBankUniProtPubChemFDAEMAReactomePharmGKBPubMedClinicalTrials.govChEMBLOpen TargetsDailyMedDrugBankUniProtPubChemFDAEMAReactomePharmGKB
Why Trace

Built to be checked, not taken on trust

The things that make an answer safe to put in front of a committee — verifiable provenance, honest evidence grading, and a strict no-verdict line.

Verified claim by claim

Every statement in a report is graded for how strong its evidence is — corroborated, single-source, or conflicting — so a reviewer sees the evidentiary state, not a black box.

CorroboratedSingle-sourceConflictingNot established

Provenance that resolves

Each citation links to an artifact you can open without us — ClinicalTrials.gov, DailyMed, PubMed. Tap through and verify it yourself.

Drug-native identity spine

Brand, generic, code, and salt forms resolve to one entity — so evidence for a molecule is never split across its aliases.

Evidence state, never a verdict

No price targets, no buy/sell calls, no risk score. DAVAI characterises the evidence and leaves the decision where it belongs — with you.

Reasoned across the graph

Drug → target → pathway → indication connections retrieved and reconciled across 26+ biomedical sources in parallel.

How it works

From question to defensible report

01

Ask a diligence question

Name a drug, target, or indication. The engine auto-detects the entities and scopes the retrieval.

02

It assembles a sourced report

Dozens of adapters run in parallel into a nine-section report — each claim carrying its citation.

03

You verify the evidence

Grades show how strong each claim is; every source is one tap from the primary artifact.

DAVAI Suite

One login. The whole platform.

Trace pairs with two sibling products — a queryable biomedical knowledge bank and a competitive-intelligence workspace. Get all three on a single subscription, arranged with our team.

Explore the Suite

Diligence you can hand to a committee.

Start free — no credit card. Generate your first sourced report and follow every claim to where it came from.